In this webinar, Sterne Kessler Directors Eldora Ellison and Trey Powers discussed the latest developments impacting post-grant proceedings in the life sciences. The webinar provided a detailed analysis of recent decisions and their implications for practice strategies, extending from prosecution through Federal Circuit appeals.
The discussion also covered the strategic use of objective evidence, such as laboratory test results, and offered guidance on avoiding pitfalls in evidence submission. Eldora and Trey also explored the application of Section 112 in recent years, focusing on challenges related to priority, written description, and enablement. Attendees will gain insights into important recent decisions and emerging trends, and their practical implications for anyone involved in post-grant proceedings.
Note: CLE is not available for On Demand viewing.
Related Professionals
Related Industries
Related Services
Receive insights from the most respected practitioners of IP law, straight to your inbox.
Subscribe for Updates